About Angioclast
We are Cambridge based biotech startup committed to transforming cancer research
Angioclast Description
angioClast is a biotech startup founded in 2015 by a group of University of Cambridge affiliates in Cambridge, UK.
Our Mission Statement: We focus on utilizing molecular techniques to develop and revolutionize the treatment of brain cancer, restoring the health of many generations to come.
More about Angioclast
http://www.angioclast.co.uk